Bayesian forecasting and prediction of tacrolimus concentrations in pediatric liver and adult renal transplant recipientsWILLIS, Charlene; STAATZ, Christine E; TETT, Susan E et al.Therapeutic drug monitoring. 2003, Vol 25, Num 2, pp 158-166, issn 0163-4356, 9 p.Article

Effects of Combinational CYP3A5 6986A>G Polymorphism in Graft Liver and Native Intestine on the Pharmacokinetics of Tacrolimus in Liver Transplant Patients: A Meta-AnalysisBUENDIA, Jefferson A; BRAMUGLIA, Guillermo; STAATZ, Christine E et al.Therapeutic drug monitoring. 2014, Vol 36, Num 4, pp 442-447, issn 0163-4356, 6 p.Article

Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantationSTAATZ, Christine E; TETT, Susan E.Clinical pharmacokinetics. 2004, Vol 43, Num 10, pp 623-653, issn 0312-5963, 31 p.Article

Comparison of two population pharmacokinetic programs, NONMEM and P-PHARM, for tacrolimusSTAATZ, Christine E; TETT, Susan E.European journal of clinical pharmacology. 2002, Vol 58, Num 9, pp 597-605, issn 0031-6970, 9 p.Article

Maximum A Posteriori Bayesian Estimation of Mycophenolic Acid Area Under the Concentration-Time Curve: Is This Clinically Useful for Dosage Prediction Yet?STAATZ, Christine E; TETT, Susan E.Clinical pharmacokinetics. 2011, Vol 50, Num 12, pp 759-772, issn 0312-5963, 14 p.Article

How Accurate and Precise Are Limited Sampling Strategies in Estimating Exposure to Mycophenolic Acid in People with Autoimmune Disease?ABD RAHMAN, Azrin N; TETT, Susan E; STAATZ, Christine E et al.Clinical pharmacokinetics. 2014, Vol 53, Num 3, pp 227-245, issn 0312-5963, 19 p.Article

Clinical Pharmacokinetics and Pharmacodynamics of Mycophenolate in Patients with Autoimmune DiseaseABD RAHMAN, Azrin N; TETT, Susan E; STAATZ, Christine E et al.Clinical pharmacokinetics. 2013, Vol 52, Num 5, pp 303-331, issn 0312-5963, 29 p.Article

Evaluation of the Mycophenolic Acid Exposure Estimation Methods Used in the APOMYGERE, FDCC, and Opticept TrialsBARRACLOUGH, Katherine A; ISBEL, Nicole M; STAATZ, Christine E et al.Transplantation. 2010, Vol 90, Num 1, pp 44-51, issn 0041-1337, 8 p.Article

Population pharmacokinetics of tacrolimus in adult kidney transplant recipientsSTAATZ, Christine E; WILLIS, Charlene; TAYLOR, Paul J et al.Clinical pharmacology and therapeutics. 2002, Vol 72, Num 6, pp 660-669, issn 0009-9236, 10 p.Article

Population Pharmacokinetics of Tacrolimus in Adult Kidney Transplant Patients: Impact of CYP3A5 Genotype on Starting DoseBERGMANN, Troels K; HENNIG, Stefanie; BARRACLOUGH, Katherine A et al.Therapeutic drug monitoring. 2014, Vol 36, Num 1, pp 62-70, issn 0163-4356, 9 p.Article

Population Pharmacokinetics of Tacrolimus in Pediatric Hematopoietic Stem Cell Transplant Recipients: New Initial Dosage Suggestions and a Model-Based Dosage Adjustment ToolWALLIN, Johan E; FRIBERG, Lena E; FASTH, Anders et al.Therapeutic drug monitoring. 2009, Vol 31, Num 4, pp 457-466, issn 0163-4356, 10 p.Article

Evaluation and Comparison of Simple Multiple Model, Richer Data Multiple Model, and Sequential Interacting Multiple Model (IMM) Bayesian Analyses of Gentamicin and Vancomycin Data Collected From Patients Undergoing Cardiothoracic SurgeryMACDONALD, Lona; STAATZ, Christine E; JELLIFFE, Roger W et al.Therapeutic drug monitoring. 2008, Vol 30, Num 1, pp 67-74, issn 0163-4356, 8 p.Article

Predictors of new onset diabetes after renal transplantationJOSS, Nicola; STAATZ, Christine E; THOMSON, Alison H et al.Clinical transplantation. 2007, Vol 21, Num 1, pp 136-143, issn 0902-0063, 8 p.Article

Population Pharmacokinetics of Tobramycin in Patients With and Without Cystic FibrosisHENNIG, Stefanie; STANDING, Joseph F; STAATZ, Christine E et al.Clinical pharmacokinetics. 2013, Vol 52, Num 4, pp 289-301, issn 0312-5963, 13 p.Article

Population pharmacokinetics of mycophenolic acid during the first week after renal transplantationSTAATZ, Christine E; DUFFULL, Stephen B; KIBERD, Bryce et al.European journal of clinical pharmacology. 2005, Vol 61, Num 7, pp 507-516, issn 0031-6970, 10 p.Article

A Differential Impact of Mycophenolic Acid, Prednisolone, and Tacrolimus Exposure on sCD30 Levels in Adult Kidney Transplant RecipientsBARRACLOUGH, Katherine A; STAATZ, Christine E; JOHNSON, David W et al.Therapeutic drug monitoring. 2013, Vol 35, Num 2, pp 240-245, issn 0163-4356, 6 p.Article

Evaluation of limited sampling strategies for total and free prednisolone in adult kidney transplant recipientsBARRACLOUGH, Katherine A; ISBEL, Nicole M; MCWHINNEY, Brett C et al.European journal of clinical pharmacology. 2011, Vol 67, Num 12, pp 1243-1252, issn 0031-6970, 10 p.Article

NRII2 Polymorphisms Are Related to Tacrolimus Dose-Adjusted Exposure and BK Viremia in Adult Kidney TransplantationBARRACLOUGH, Katherine A; ISBEL, Nicole M; ROCKETT, Rebecca J et al.Transplantation. 2012, Vol 94, Num 10, pp 1025-1032, issn 0041-1337, 8 p.Article

Population pharmacokinetics of tacrolimus in children who receive cut-down or full liver transplantsSTAATZ, Christine E; TAYLOR, Paul J; LYNCH, Stephen V et al.Transplantation. 2001, Vol 72, Num 6, pp 1056-1061, issn 0041-1337Article